Targeting GPRC5D With Talquetamab: A New Frontier in Bispecific Antibody Therapy for Relapsed/Refractory Multiple Myeloma.
Article in Annals of Pharmacotherapy (August 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Article in Annals of Pharmacotherapy (August 2024)
Article in Nature Reviews Clinical Oncology (July 2024)
Article in Cancer Drug Resistance (June 2024)